ZA986364B - Novel method of treatment. - Google Patents

Novel method of treatment.

Info

Publication number: ZA986364B
Authority: ZA; South Africa
Prior art keywords: treatment; novel method; novel
Prior art date: 1997-07-18

Application number

ZA9806364A

Inventor

Robin Edwin Buckingham

Stephen Alistair Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-18

Filing date

1998-07-17

Publication date

2000-01-17

1998-07-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-01-17 Publication of ZA986364B publication Critical patent/ZA986364B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

ZA9806364A 1997-07-18 1998-07-17 Novel method of treatment. ZA986364B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9715298A GB9715298D0 (en)	1997-07-18	1997-07-18	Novel method of treatment

Publications (1)

Publication Number	Publication Date
ZA986364B true ZA986364B (en)	2000-01-17

Family

ID=10816170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9806364A ZA986364B (en)	1997-07-18	1998-07-17	Novel method of treatment.

Country Status (27)

Country	Link
EP (1)	EP1001784A1 (en)
JP (1)	JP2001510160A (en)
KR (1)	KR20010021952A (en)
CN (1)	CN1263467A (en)
AP (1)	AP2000001735A0 (en)
AR (2)	AR016350A1 (en)
AU (1)	AU8449098A (en)
BG (1)	BG104062A (en)
BR (1)	BR9810292A (en)
CA (1)	CA2297133A1 (en)
CO (1)	CO4940489A1 (en)
DZ (1)	DZ2563A1 (en)
EA (1)	EA200000140A1 (en)
GB (1)	GB9715298D0 (en)
HU (1)	HUP0003626A3 (en)
ID (1)	ID23804A (en)
IL (1)	IL133907A0 (en)
MA (1)	MA24608A1 (en)
NO (1)	NO20000230D0 (en)
OA (1)	OA11312A (en)
PE (1)	PE99499A1 (en)
PL (1)	PL338140A1 (en)
SK (1)	SK612000A3 (en)
TR (1)	TR200000133T2 (en)
UY (1)	UY25101A1 (en)
WO (1)	WO1999003478A1 (en)
ZA (1)	ZA986364B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW438587B (en) *	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
EP1133312B8 (en)	1999-06-21	2007-10-17	Eli Lilly And Company	Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
CN1400908A (en) *	2000-01-21	2003-03-05	诺瓦提斯公司	Combinations comprising dipeptidylpepidase IV inhibitors and antidiabetic agents
JP4917712B2 (en) *	2000-02-24	2012-04-18	武田薬品工業株式会社	Concomitant medication
US20030040490A1 (en) *	2000-02-24	2003-02-27	Yasuo Sugiyama	Drugs containing combined active ingredients
EP1738751B1 (en)	2001-01-12	2011-05-11	Sun Pharma Advanced Research Company Ltd	Spaced drug delivery system
FR2832930A1 (en) *	2001-12-03	2003-06-06	Lipha	PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
TWI339586B (en)	2003-10-31	2011-04-01	Takeda Chemical Industries Ltd	Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) *	2006-07-14	2011-03-30	北京华安佛医药研究中心有限公司	Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993003724A1 (en) *	1991-08-26	1993-03-04	The Upjohn Company	Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) *	1994-09-28	1999-06-29	Shaman Pharmaceuticals, Inc.	Hypoglycemic agent from cryptolepis
TW438587B (en) *	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1997
- 1997-07-18 GB GB9715298A patent/GB9715298D0/en active Pending
1998
- 1998-07-15 DZ DZ980173A patent/DZ2563A1/en active
- 1998-07-16 AU AU84490/98A patent/AU8449098A/en not_active Abandoned
- 1998-07-16 IL IL13390798A patent/IL133907A0/en unknown
- 1998-07-16 MA MA25172A patent/MA24608A1/en unknown
- 1998-07-16 EP EP98935129A patent/EP1001784A1/en not_active Withdrawn
- 1998-07-16 PL PL98338140A patent/PL338140A1/en unknown
- 1998-07-16 CN CN98807147A patent/CN1263467A/en active Pending
- 1998-07-16 EA EA200000140A patent/EA200000140A1/en unknown
- 1998-07-16 CA CA002297133A patent/CA2297133A1/en not_active Abandoned
- 1998-07-16 ID IDW20000077A patent/ID23804A/en unknown
- 1998-07-16 SK SK61-2000A patent/SK612000A3/en unknown
- 1998-07-16 HU HU0003626A patent/HUP0003626A3/en unknown
- 1998-07-16 TR TR2000/00133T patent/TR200000133T2/en unknown
- 1998-07-16 JP JP2000502777A patent/JP2001510160A/en active Pending
- 1998-07-16 AR ARP980103482A patent/AR016350A1/en unknown
- 1998-07-16 PE PE1998000630A patent/PE99499A1/en not_active Application Discontinuation
- 1998-07-16 WO PCT/GB1998/002112 patent/WO1999003478A1/en not_active Application Discontinuation
- 1998-07-16 BR BR9810292-3A patent/BR9810292A/en not_active IP Right Cessation
- 1998-07-16 KR KR1020007000517A patent/KR20010021952A/en not_active Withdrawn
- 1998-07-17 ZA ZA9806364A patent/ZA986364B/en unknown
- 1998-07-17 UY UY25101A patent/UY25101A1/en not_active Application Discontinuation
- 1998-07-17 CO CO98040749A patent/CO4940489A1/en unknown
1999
- 1999-06-28 AR ARP990103110A patent/AR019724A2/en unknown
2000
- 2000-01-06 BG BG104062A patent/BG104062A/en unknown
- 2000-01-14 AP APAP/P/2000/001735A patent/AP2000001735A0/en unknown
- 2000-01-17 NO NO20000230A patent/NO20000230D0/en not_active Application Discontinuation
- 2000-01-18 OA OA1200000013A patent/OA11312A/en unknown

Also Published As

Publication number	Publication date
CO4940489A1 (en)	2000-07-24
KR20010021952A (en)	2001-03-15
ID23804A (en)	2000-05-11
GB9715298D0 (en)	1997-09-24
TR200000133T2 (en)	2000-09-21
JP2001510160A (en)	2001-07-31
DZ2563A1 (en)	2003-02-15
NO20000230L (en)	2000-01-17
BR9810292A (en)	2000-09-19
WO1999003478A1 (en)	1999-01-28
BG104062A (en)	2000-11-30
IL133907A0 (en)	2001-04-30
AU8449098A (en)	1999-02-10
AR019724A2 (en)	2002-03-13
NO20000230D0 (en)	2000-01-17
CA2297133A1 (en)	1999-01-28
EP1001784A1 (en)	2000-05-24
UY25101A1 (en)	2000-12-29
OA11312A (en)	2003-10-24
PE99499A1 (en)	1999-12-18
HUP0003626A2 (en)	2001-05-28
AP2000001735A0 (en)	2000-01-16
CN1263467A (en)	2000-08-16
SK612000A3 (en)	2000-07-11
EA200000140A1 (en)	2000-06-26
HUP0003626A3 (en)	2001-12-28
PL338140A1 (en)	2000-09-25
MA24608A1 (en)	1999-04-01
AR016350A1 (en)	2001-07-04

Publication	Publication Date	Title
ZA200108446B (en)	2003-08-27	Novel method of treatment.
ZA977564B (en)	1999-02-22	Method of treatment
ZA986363B (en)	2000-01-17	Novel method of treatment.
ZA985237B (en)	2000-02-17	Novel method of treatment.
GB9605828D0 (en)	1996-05-22	Treatment method
GB9707693D0 (en)	1997-06-04	Novel method of treatment
ZA986364B (en)	2000-01-17	Novel method of treatment.
ZA986365B (en)	2000-01-17	Novel method of treatment.
ZA977867B (en)	1998-05-27	Method of treatment.
GB9714841D0 (en)	1997-09-17	Treatment method
ZA973988B (en)	1998-11-09	Method of treatment
ZA200007396B (en)	2002-02-27	Method of treatment.
AP2005003432A0 (en)	2005-12-31	Novel method of treatment.
ZA985235B (en)	2000-02-17	Novel method of treatment.
ZA985238B (en)	2000-02-17	Novel method of treatment.
ZA985236B (en)	2000-02-17	Novel method of treatment.
ZA987316B (en)	1999-03-15	Method of treatment
GB9724289D0 (en)	1998-01-14	Method of treatment
ZA963472B (en)	1998-02-02	Method of treatment.
GB9703102D0 (en)	1997-04-02	Treatment method
EG24158A (en)	2008-08-20	Novel method of treatment
GB9824871D0 (en)	1999-01-06	Novel method of treatment
GB9824789D0 (en)	1999-01-06	Novel method of treatment
GB9824790D0 (en)	1999-01-06	Novel method of treatment
SI1135128T1 (en)	2007-12-31	Novel method of treatment